abbreviated new drug application

(redirected from ANDA)
Also found in: Acronyms, Encyclopedia, Wikipedia.

Abbreviated New Drug Application

A simplified submission to the US Food & Drug Administration (FDA) requesting authorization to market a new  formulation of an existing drug or an investigational drug similar to an already approved drug, for which both its therapeutic indications and formulation were previously approved by the FDA.

abbreviated new drug application

Pharmacology An application made in the US by a pharmaceutical company requesting authority to market a 'new' drug for which both its therapeutic indications and formulation were previously approved by the FDA in another similar drug. See Me too drug.

ab·bre·vi·a·ted new drug ap·pli·ca·tion

(ă-brē'vē-ā-tĕd nū drŭg ap'li-kā'shŭn)
A request by a pharmaceutical company to market and sell a pharmaceutical that is essentially the same as another, which has already been granted such approval.

abbreviated new drug application



A formal request to the U.S. Food and Drug Administration to approve a generic drug that is a copy of a patented agent already approved for use.
References in periodicals archive ?
This acquisition of the Sandoz's ANDAs enhances CASI's strategic focus to build a robust pipeline and commercialize quality drug candidates in China, including entecavir, an antiviral medication used in the treatment of hepatitis B viral infection (HBV), said CASI's CEO Ken Ren, PhD.
Although ANDA filings constitute only about 10% of all patent litigation in U.
Undoubtedly, the appeal will be closely watched and should provide some measure of clarity about how Daimler will be applied in ANDA litigation.
Among the report's key findings is that ANDA patent litigation has declined for the first time in three years from a high of 468 cases in 2015 to 316 cases in 2016 which represents a nearly 32.
In theory, there are four different ways an ANDA specification can relate to infringement.
M2 EQUITYBITES-June 6, 2012-IGI Laboratories Inc files sixth ANDA with US FDA(C)2012 M2 COMMUNICATIONS http://www.